Home - Products - Others - Other Targets - threo-Guaiacylglycerol beta-coniferyl ether

threo-Guaiacylglycerol beta-coniferyl ether

CAS No. 869799-76-8

threo-Guaiacylglycerol beta-coniferyl ether( —— )

Catalog No. M31083 CAS No. 869799-76-8

Threo-Guaiacylglycerol beta-coniferyl ether displays significant inhibitory effects on NO production.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 531 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    threo-Guaiacylglycerol beta-coniferyl ether
  • Note
    Research use only, not for human use.
  • Brief Description
    Threo-Guaiacylglycerol beta-coniferyl ether displays significant inhibitory effects on NO production.
  • Description
    Threo-Guaiacylglycerol beta-coniferyl ether displays significant inhibitory effects on NO production.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    869799-76-8
  • Formula Weight
    376.4
  • Molecular Formula
    C20H24O7
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • anemarsaponin B

    Anemarsaponin B has anti-inflammatory effect in LPS-treated RAW 264.7macrophages, the effect is associated with the inhibition of NF-κB transcriptional activity, possibly via the p38 MAP kinase pathway.

  • Activated Protein C ...

    Activated Protein C (390-404), human is a peptide of the activated protein C (a vitamin K-dependent serine protease), potently inhibits APC anticoagulant activity.

  • Darapladib-impurity

    Darapladib-impurity is the impurity of Darapladib. Darapladib inhibits lipoprotein-associated phospholipase A2 (Lp-PLA2).